Inhibition of phosphodiesterase type IV suppresses human immunodeficiency virus type 1 replication and cytokine production in primary T cells: Involvement of NF-κB and NFAT

Journal of Virology

Volumn 72, Issue 6, 1998, Pages 4712-4720

  Navarro, Joaquín ^a   Punzón, Carmen ^b   Jiménez, José Luis ^a   Fernández Cruz, Eduardo ^b   Pizarro, Angel ^c   Fresno, Manuel ^b   Muñoz Fernández, M Angeles ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; BUCLADESINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PENTOXIFYLLINE; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LONG TERMINAL REPEAT; NORMAL HUMAN; PRIORITY JOURNAL; REPORTER GENE; T LYMPHOCYTE ACTIVATION; VIRUS REPLICATION;

EID: 0031902918     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.6.4712-4720.1998     Document Type: Article

References (74)

1. Adachi, A., H. E. Gendelman, S. Koenig, R. Folks, R. Willey, A. Rabson, and M. A. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-289.
2. Alcami, J., T. Lain de Lera, L. Folgueira, M. A. Pedraza, J.-M. Jacque, F. Bachelerie, A. R. Noriega, R. T. Hay, D. Harrich, R. B. Gaynor, J.-L. Virelizier, and F. Arenzana-Seisdedos. 1995. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J. 14:1552-1560.
3. Angel, J. B., B. M. Saget, S. P. Walsh, T. F. Greten, C. A. Dinarello, P. R. Skolnik, and S. Endres. 1995. Rolipram, a specific type IV phosphodiesterase inhibitor, is a potent inhibitor of HIV-1 replication. AIDS 9:1137-1144.
4. Angel, J. B., B. M. Saget, M. Z. Wang, A. Wang, C. A. Dinarello, and P. R. Skolnik. 1995. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor α-independent mechanism. J. Interferon Cytokine Res. 15: 575-584.
5. Antoni, B. A., S. B. Stein, and A. B. Rabson. 1994. Regulation of human immunodeficiency virus infection: implications for pathogenesis. Adv. Virus Res. 43:53-145.
6. Bachelerie, F., J. Alcami, F. Arenzana-Seisdedos, U. Hazan, and J. L. Virelizier. 1991. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 350:709-712.
7. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
8. Baldwin, A. S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
9. Barcellini, W., G. P. Rizzardi, J. B. Marriott, C. Fain, R. J. Shattock, P. L. Meroni, G. Poli, and A. G. Dalgleish. 1996. Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumor necrosis factor (TNF)-α and TNF receptor type 1 in a promonocytic cell line. AIDS 10:835-842.
10. Bassuk, A. G., R. A. Anandapa, and J. M. Leiden. 1997. Physical interactions between EtS and NF-κB/NFAT proteins play an important role in their cooperative activation of the human immunodeficiency virus enhancer in T cells. J. Virol. 71:3563-3573.
11. Beavo, J. A., M. Conti, and R. J. Heaslip. 1994. Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46:399-405.
12. Benson, M. 1993. Immune modulation in HIV infection: fact or fantasy? J. Acquired Immune Defic. Syndr. 6:561-567.
13. Bukrinsky, M. L., T. L. Stanwick, M. P. Dempsey, and M. Stevenson. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-427.
14. Chen, D., and E. V. Rottenberg. 1994. Interleukin 2 transcription factors as molecular targets of cAMP inhibition: delayed inhibition kinetics and combinatorial transcription roles. J. Exp. Med. 179:931-942.
15. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
16. Crabtree, G. R., and N. A. Clipstone. 1994. Signal transcription between the plasma membrane and nucleus of T lymphocytes. Annu. Rev. Biochem. 63: 1045-1083.
17. Cullen, B. R. 1991. Regulation of immunodeficiency virus replication. Annu. Rev. Microbiol. 45:423-427.
18. Davis, C. W. 1984. Assessment of selective inhibition of rat cerebral cortical calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions. Biochim. Biophys. Acta 797:354-362.
19. Debuze, B. J. 1994. Pentoxifylline for the treatment of infection with human immunodeficiency virus. Clin. Infect. Dis. 18:285-287.
20. Demarchi, F., P. D'Agaro, A. Falaschi, and M. Glacca. 1993. In vivo foot-printing analysis of constitutive and inducible protein-DNA interaction at the long terminal repeat of human immunodeficiency virus type 1. J. Virol. 67:7450-7460.
21. Di Somma, M., M. B. Majolini, S. E. Burastero, J. L. Telford, and C. T. Bardari. 1997. Cyclosporin A sensitivity of the HIV long terminal repeat identifies distinct pp561ck-dependent pathways activated by CD4 triggering. Eur. J. Immunol. 26:2181-2188.
22. Doerre, S., P. Sista, S-C. Sun, D. W. Ballard, and W. C. Greene. 1993. The c-rel protooncogene product represses NF-κB p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 90:1023-1027.
23. Duh, E. J., W. J. Maury, T. M. Folks, A. S. Fauci, and A. B. Rabson. 1990. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86:5974-5978.
24. Durand, D. B., J. P. Shaw, M. R. Bush, R. E. Replogle, R. Belagaje, and G. R. Crabtree. 1988. Characterization of antigen receptor response elements within the interleukin 2 enhancer. Mol. Cell. Biol. 8:1715-1724.
25. Eckmann, F., K. Fichte, U. Meya, M. Saster, and Y. Hernandez. 1988. Rolipram in major depression: results of a double-blind comparative study with amitriptyline. Curr. Ther. Res. 43:291-295.
26. Essayen, D. M., S. K. Huang, R. J. Undem, A. Kagey-Sobotka, and L. M. Lichtenstein. 1994. Modulation of antigen and mitogen-induced proliferative responses of peripheral blood mononuclear cells by nonselective and isozyme selective cyclic nucleotide phosphodiesterase inhibitors. J. Immunol. 153:3408.
27. Fauci, A. S. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011-1018.
28. Fauci, A. S. 1996. Host factors and the pathogenesis of HIV-induced disease: implications for therapy. Science 384:529-534.
29. Flanagan, W. M., B. Corthesy, R. J. Bram, and G. R. Crabtree. 1991. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature 352:803-807.
30. Foissier, L., M. Lonchampt, F. Cogé, and E. Canet. 1996. In vitro down-regulation of antigen-induced IL-5 gene expression and protein production by cAMP-specific phosphodiesterase type 4 inhibitor. J. Pharmacol. Exp. Ther. 278:1484-1490.
31. Folks, T. M., K. A. Clouse, J. Justment, A. Rabson, E. Due, J. H. Kehrl, and A. S. Fauci. 1989. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86:2365-2369.
32. Folks, T. M., J. Kelly, S. Benn, A. Kinter, J. Justement, J. Gold, R. Refield, K. W. Sell, and S. Fauci. 1986. Susceptibility of normal human lymphocytes to infection with HTLV III/LAV. J. Immunol. 136:4049.
33. Gaynor, R. 1992. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 6:347-363.
34. Haraguchi, S., R. A. Good, and N. K. Day. 1995. Immunosuppressive retroviral peptides: cAMP and cytokine patterns. Immunol. Today 15:595-603.
35. Harrich, D., J. Garcia, W. Wu, R. Mitsuyasu, J. Gonzalez, and R. Gaynor. 1989. Role of the Sp1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat. J. Virol. 63:2585-2591.
36. Ho, H.-Y., H.-H. Lee, and M.-Z. Lai. 1997. Overexpression of mitogen activated protein kinase kinase kinase reverted cAMP inhibition of NF-κB activation in T cells. Eur. J. Immunol. 27:222-226.
37. Jamieson, C., P. G. McCaffrey, A. Rao, and R. Sen. 1991. Physiologic activation of T cells via the T cell receptor induces NF-κB. J. Immunol. 147: 416-420.
38. Karpas, A., M. Lowdell, S. K. Jacobson, and F. Hill. 1992. Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506. Proc. Natl. Acad. Sci. USA 89:8351-8355.
39. Kinoshita, S., L. Su, M. Amano, L. A. Timmerman, H. Kaneshima, and G. P. Nolan. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235-244.
40. Kinter, A. L., G. Poli, and A. S. Fauci. 1995. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. J. Immunol. 154:2448-2459.
41. Lee, H. J., E. S. Masuda, N. Arai, K. Arai, and T. Yokota. 1995. Definition of cis-regulatory elements of the mouse interleukin-5 gene promoter: involvement of nuclear factor of activated T cell-related factors in interleukin-5 expression. J. Biol. Chem. 270:17541-17550.
42. Leiden, J. M., C-Y. Wang, B. Petryniak, D. M. Markovitz, G. J. Nabel, and C. B. Thompson. 1992. A novel Ets-related transcription factor, Elf-1, binds to human immunodeficiency virus type 2 regulatory elements that are required for inducible trans activation in T cells. J. Virol. 66:5890-5897.
43. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
44. Liou, H. C., and D. Baltimore. 1993. Regulation of the NF-kappa B/rel transcription factor and I kappa B inhibitor system. Curr. Opin. Cell. Biol. 5: 477-487.
45. Liu, J., N. D. Perkins, R. M. Schmid, and G. J. Nabel. 1992. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type 1 transcription. J. Virol. 66:3883-3887.
46. Lowenthal, J. W., D. W. Ballard, H. Bohnlein, E. Bogerd, and W. C. Greene. 1989. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. Proc. Natl. Acad. Sci. USA 86:2331-2335.
47. Lu, Y. C., N. Touzjian, M. Stenzel, T. Dorfman, J. G. Sodroski, and W. A. Haseltine. 1990. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J. Virol. 64:5226-5229.
48. Majello, B., P. De Luca, G. Hagen, G. Suske, and L. Lania. 1994. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1. Nucleic Acids Res. 22:4914-4921.
49. Markovitz, D. M., M. C. Hannibal, M. J. Smith, R. Cossma, and G. J. Nabel. 1992. Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1. J. Virol. 66:3961-3965.
50. McCaffrey, P. G., C. Luo, T. K. Kerpolla, J. Jain, T. M. Badalina, A. M. Ho, E. Burgeon, W. S. Lane, J. N. Lambert, T. Curran, G. L. Verdine, A. Rao, and P. G. Hogan. 1993. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp. Science 262:750-754.
51. Molitor, J. A., W. H. Walker, S. Doerre, D. W. Ballard, and W. C. Greene. 1990. NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc. Natl. Acad. Sci. USA 87:10028-10032.
52. Muñoz-Fernández, M. A., J. Navarro, A. Garcia, C. Punzón, E. Fernández-Cruz, and M. Fresno. 1997. Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor kappa-B activation. J. Allergy Clin. Immunol. 100:838-845.
53. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326: 711-713.
54. Navarro, J., M. C. Punzón, A. Pizarro, E. Fernández-Cruz, M. Fresno, and M. A. Muñoz-Fernández. 1996. Pentoxifylline inhibits acute HIV-1-replication in human T cells by a mechanism not involving inhibition of tumor necrosis factor synthesis or nuclear factor kappa-B activation. AIDS 10: 469-475.
55. Northrop, J. P., S. N. Ho, L. Chen, D. J. Thomas, L. A. Timmerman, G. P. Nolan, A. Admon, and G. R. Crabtree. 1994. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369: 497-502.
56. Osborn, L., S. Kunkel, and G. J. Nabel. 1989. Tumor necrosis factor alpha and interleukin 1 stimulate the immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc. Natl. Acad. Sci. USA 86:2336-2340.
57. Perkins, N. D., N. Lawrence Edwards, C. S. Duckett, A. B. Agranoff, R. M. Scmid, and G. J. Nabel. 1993. A cooperative interaction between NF-κB and Sp1 is required for HIV-1 enhancer activation. EMBO J. 12:3551-3558.
58. Pimentel-Muiños, F. X, J. Mazana, and M. Fresno. 1995. Biphasic control of nuclear factor-κB activation by the T cell receptor complex: role of tumor necrosis factor. Eur. J. Immunol. 25:179-186.
59. Pimentel-Muiños, F. X., M. A. Muñoz-Fernández, and M. Fresno. 1994. Control of T lymphocyte activation and interleukin-2 receptor expression by endogenously secreted lymphokines. J. Immunol. 152:5714-5722.
60. Platzer, B., C. Meisel, K. Vogt, M. Platzer, and H. D. Volk. 1994. Up-regulation of monocytic IL-10 by tumor necrosis factor-α and cAMP elevating drugs. Int. Immunol. 4:517-523.
61. Poli, G., and A. S. Fauci. 1993. Cytokine modulation of HIV expression. Semin. Immunol. 5:165-173.
62. Punzón, M. C., J. Navarro, A. Pizarro, M. A. Muñoz-Fernández, and M. Fresno. Unpublished data.
63. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NF-AT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
64. Robiseck, S. A., D. K. Blanchard, J. Y. Djeu, J. J. Krzanawski, A. Szentivanyi, and J. B. Polson. 1991. Multiple high-affinity cAMP-phosphodiesterases in human T-lymphocytes. Biochem. Pharmacol. 42:869-876.
65. Schwaniger, M., R. Blume, E. Getjen, G. Lux, and W. Knepel. 1993. Inhibition of a cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J. Biol. Chem. 288: 23111-23115.
66. Semmler, J., H. Wachtel, and S. Endres. 1993. The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-α production by human mononuclear cells. Int. J. Immunopharmacol. 15:409-413.
67. Seth, A., D. R. Hodge, D. M. Thompson, L. Robinson, A. Panaylotakis, D. K. Watson, and T. S. Papas. 1993. ETS family proteins activate transcription from HIV-1 long terminal repeat. AIDS Res. Hum. Retroviruses 9:1017-1023.
68. Sommer, N., P. A. Löschmann, G. H. Northoff, M. Weller, A. Steinbrecher, J. P. Steinbach, R. Lichtenfels, R. Meyermann, A. Riethmüller, A. Fontana, J. Dighgans, and R. Martin. 1995. The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis. Nat. Med. 3:244-248.
69. Tamir, A., and N. Isakov. 1994. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J. Immunol. 152:3391-3399.
70. Teixeira, M. M., R. W. Griswood, N. Cooper, and P. G. Hellewell. 1997. Phosphodiesterase (PDE) 4 inhibitors: anti-inflammatory drugs of the future? Trends Pharmacol. Sci. 18:1640.
71. Tsuruta, L., H-Y. Lee, E. S. Masuda, N. Koyano-Nakagawa, N. Arai, K. Arai, and T. Yokota. 1995. Cyclic AMP inhibits expression of the IL-2 gene through the nuclear factor of activated T cells (NF-AT) site, and transfection of NF-AT cDNAs abrogates the sensitivity of EL-4 cells to cyclic AMP. J. Immunol. 154:5255-5264.
72. Vyakarnam, A., A. J. McKeating, A. Meager, and P. C. Beverly. 1990. Tumor necrosis factors (α, β) induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 4:21-27.
73. Weissman, D., G. Poli, and A. S. Fauci. 1994. IL-10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and IL-6 induction of the virus. AIDS Res Hum. Retroviruses 10: 1199-1206.
74. Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals labile, latent viral structure. Cell 61:213-222.